WHO guidelines on HIV and Infant Feeding in 2010 for the first time recommended the use of antiretroviral drugs to prevent postnatal transmission of HIV through breastfeeding. This resulted in a major change from an individualised counselling approach toward a public health approach regarding how maternal and child health services should routinely promote and support infant feeding practices among mothers living with HIV
This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.
This monograph is a guide to monitoring and evaluating the collaborative TB/HIV activities. It presents a rationale for collaborative activities, an overview of monitoring indicators, methods of collecting standardized data, and help in interpreting and disseminating the data. It argues for consistency in the way collaborative activities are performed and data collected. The guide presents a core set of internationally accepted and standardized indicators for measuring and evaluating performance.
This wall chart in the form of a flow chart provides information on the process to be followed by health care workers during testing and counseling women after delivery as part of the prevention of mother-to-child transmission (PMTCT) of HIV. The chart lists counseling procedures to be followed in pre-test session before offering the test, if the test is declined, if the test is performed and the result is negative, and if the test is performed and the result is positive.
This monograph presents guidelines developed by the Scientific Panel of the Working Group on Directly Observed Treatment, short-course (DOTS)-Plus for multidrug-resistant TB (MDR-TB). The World Health Organization created the Working Group on DOTS-Plus for MDR-TB in 1999. The guidelines describe criteria and technical standards that must be in place before beginning a DOTS-Plus pilot project to treat MDR-TB patients and provide an international standard for the structure and function of pilot projects.
This report gives the results of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance (DRS), conducted between 1996 and 1999, three years after the initial survey of 35 geographical settings, with the aim of collecting worldwide information on drug resistance of Mycobacterium TB.
This monograph describes the major characteristics of the private health sector role in TB care and presents efforts to address the issue. The monograph reports the result of a global situation assessment initiated by the World Health Organization (WHO) in 1999 to investigate the extent and nature of private involvement in TB care. Twenty-three countries in the six WHO regions were visited as part of the assessment. The assessment confirmed a substantial TB caseload and unsatisfactory management practices among private practitioners.